CG Oncology, Inc. financial data

Symbol
CGON on Nasdaq
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 27 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2474% % -41%
Debt-to-equity 4.8% % 95%
Return On Equity -23% % -55%
Return On Assets -22% % -52%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84,435,200 shares 11%
Common Stock, Shares, Outstanding 80,689,128 shares 6%
Common Stock, Value, Issued $8,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 77,303,440 shares 24%
Weighted Average Number of Shares Outstanding, Diluted 77,303,440 shares 24%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $116,641,000 USD 42%
General and Administrative Expense $73,526,000 USD 118%
Operating Income (Loss) $190,774,000 USD -66%
Nonoperating Income (Expense) $29,779,000 USD 12%
Net Income (Loss) Attributable to Parent $160,995,000 USD -83%
Earnings Per Share, Basic -2.08 USD/shares -48%
Earnings Per Share, Diluted -2.08 USD/shares -48%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $32,490,000 USD -87%
Marketable Securities, Current $709,665,000 USD 46%
Inventory, Net $1,565,000 USD
Assets, Current $759,475,000 USD 0.7%
Property, Plant and Equipment, Net $15,596,000 USD 5634%
Operating Lease, Right-of-Use Asset $3,971,000 USD 1697%
Goodwill $10,297,000 USD
Other Assets, Noncurrent $1,678,000 USD 1685%
Assets $791,592,000 USD 4.9%
Accounts Payable, Current $5,714,000 USD -12%
Liabilities, Current $30,836,000 USD 44%
Operating Lease, Liability, Noncurrent $3,106,000 USD 5873%
Other Liabilities, Noncurrent $1,741,000 USD
Liabilities $38,990,000 USD 82%
Retained Earnings (Accumulated Deficit) $378,976,000 USD -74%
Stockholders' Equity Attributable to Parent $752,602,000 USD 2.6%
Liabilities and Equity $791,592,000 USD 4.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 700,000,000 shares 0%
Common Stock, Shares, Issued 80,689,128 shares 6%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $32,490,000 USD -87%
Deferred Tax Assets, Valuation Allowance $93,287,000 USD 65%
Deferred Tax Assets, Gross $95,492,000 USD 69%
Operating Lease, Liability $4,021,000 USD 1589%
Depreciation $500,000 USD
Lessee, Operating Lease, Liability, to be Paid $4,618,000 USD 1832%
Property, Plant and Equipment, Gross $17,070,000 USD 4655%
Operating Lease, Liability, Current $915,000 USD 392%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,137,000 USD 2087%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,162,000 USD 521%
Operating Lease, Weighted Average Discount Rate, Percent 0.0689 pure 323%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $597,000 USD 59600%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,116,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $64,432,000 USD 86%
Unrecognized Tax Benefits $1,868,000 USD 34%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,039,000 USD
Operating Lease, Payments $588,000 USD 164%
Additional Paid in Capital $1,131,570,000 USD 19%
Deferred Tax Assets, Net of Valuation Allowance $93,257,000 USD 65%
Share-based Payment Arrangement, Expense $26,676,000 USD 134%